Journals / Türk Osteoporoz Dergisi / 2021 / Cilt: 27 - Sayı: 1

Sociodemographic and Clinical Characteristics of Patients with Behçet’s Disease Followed Up in the Physical Therapy and Rehabilitation Department of a Tertiary Hospital

Üçüncü Basamak Bir Hastanenin Fizik Tedavi ve Rehabilitasyon Kliniği Tarafından Takip Edilen Behçet Hastalarının Sosyodemografik ve Klinik Özellikleri

Pages
14–19
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, it is very important to systematically evaluate patients with BD and to arrange appropriate and effective treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Behçet’s disease (BD) is a multisystemic inflammatory disease that causes significant morbidity worldwide.
📊
Key Findings & Data:In this study, we aimed to evaluate the clinical and demographic characteristics of the patients with BD.Materials and Methods: Patients admitted to our physical medicine and rehabilitation clinic between January 2015 and December 2018 were evaluated retrospectively.
💡
Conclusion & Impact:Therefore, it is very important to systematically evaluate patients with BD and to arrange appropriate and effective treatment
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Behçet’s disease (BD) is a multisystemic inflammatory disease that causes significant morbidity worldwide. In this study, we aimed to evaluate the clinical and demographic characteristics of the patients with BD.Materials and Methods: Patients admitted to our physical medicine and rehabilitation clinic between January 2015 and December 2018 were evaluated retrospectively. One hundred sixty patients who met the diagnostic criteria of the International Study Group for BD were included in the study. In addition to the patients’ demographic characteristics, their clinical features, including age at onset, symptoms on initial admission, disease duration, systemic/organ involvement and medical treatments used, were recorded.Results: The mean age of the 160 patients included in the study was 40.48±10.0 [minimum (min): 19, maximum (max): 72]. The mean age at disease onset was 30.54±8.46 (min: 14, max: 62). The most common involvement type in BD was mucocutaneous manifestations, and oral aphthae were the most common mucocutaneous symptom, with an occurrence rate of 100%. Regarding clinical manifestations, 36.3% (n=58) of patients showed ocular involvement, 16.9% (n=27) had vascular involvement and 15% (n=24) had musculoskeletal involvement. The rarest involvement was that of the genitourinary system, with a rate of 0.6% (n=1). Colchicine was the most commonly used therapeutic agent, whereas steroids, azathioprine, cyclosporine and various biologicals could also be used, depending on clinical status.Conclusion: The results of our study suggest that, although the most common manifestation of BD is mucocutaneous involvement, the involvements of various systems, such as the ocular, musculoskeletal and neurological systems, are not rare and are associated with severe morbidity and mortality. Treatment modalities vary according to the systems and organs involved. Therefore, it is very important to systematically evaluate patients with BD and to arrange appropriate and effective treatment

Özet

Amaç: Behçet hastalığı (BH) dünyada önemli morbiditelere neden olan, multisistemik enflamatuvar bir hastalıktır. Bu çalışmada BH tanılı hastalarımızın klinik ve demografik özelliklerini incelemeyi amaçladık. Gereç ve Yöntem: Ocak 2015-Aralık 2018 tarihleri arasında fiziksel tıp ve rehabilitasyon kliniğine başvuran hastaların kayıtları retrospektif olarak incelendi. Uluslararası Behçet Hastalığı Çalışma Grubu’nun tanı kriterlerini karşılayan 160 hasta çalışmaya dahil edildi. Hastaların demografik özelliklerine ek olarak hastalığın başlangıç yaşı, ilk başvuru yakınması, hastalık süresi, sistemik bulgular ve kullanılan medikal tedaviler de dahil olmak üzere klinik özellikler kayıt altına alındı. Bulgular: Çalışmaya alınan 160 hastanın yaş ortalaması 40,48±10,0 [minimum (min): 19, maksimum (maks): 72] idi. Hastalığın ortalama başlangıç yaşı 30,54±8,46 (min: 14, maks: 62) olarak hesaplandı. Hastalığın en sık tuttuğu sistemlerin başında deri yer alırken; en sık deri bulgusu %100 ile oral aftlardı. Sırasıyla diğer en sık tutulum bölgeleri %36,3 (n=58) ile göz, %16,9 (n=27) ile vasküler yapılar ve %15 (n=24) ile eklemlerdi. En nadir tutulum %0,6 (n=1) ile genitoüriner sistemdi. Tedavide en sık kullanılan ajan kolşisin olup hastanın klinik durumuna göre steroidler, azatiopürin, siklosporin ve çeşitli biyolojik ilaçlar tedavide kullanılan farklı gruplardan ajanlardır. Sonuç: Çalışmamızın sonuçları BH’nin en sık görülen tutulum şekli mukokütanöz tutulum olsa da; oküler, kas-iskelet sistemi ve nörolojik sistem tutulumu gibi ciddi morbidite ve mortalite ile ilişkili farklı tutulumların da nadir olmadığını göstermektedir. Tedavi, tutulan sistem ve organlara göre değişir. Bu nedenle, BH hastalarını sistematik olarak değerlendirmek ve uygun ve yeterli tedaviyi düzenlemek çok önemlidir.

🔖

Cite This Article

DEMİR, O., YILMAZ, N. (2022). Sociodemographic and Clinical Characteristics of Patients with Behçet’s Disease Followed Up in the Physical Therapy and Rehabilitation Department of a Tertiary Hospital. Türk Osteoporoz Dergisi, Cilt: 27 - Sayı: 1, 14–19. https://ajindex.com/articles/639600

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Behcet H. Uber rezidiverende, aphtose durch ein Virus verursachte Geschwure am Mund, am Auge, und den Genitalien. Dermat Wochensch 1937;105:1152-7
  2. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990;335:1078-80
  3. Yurdakul S, Günaydin I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y, et al. The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol 1988;15:820-2
  4. Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol 2003;42:803-6
  5. Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3:148-55
  6. Tsuyoshi S, Mitsuhiro T, Noboru S, Goro I. Behçet’s disease. Journal Rheumatology 2002;12:134-6
  7. O’Neil TW, Rigby AS, McHugh S, Silman AJ, Barnes C. On behalf of the international study group for behçet’s disease. Regional differences in clinical manifestations of Behçet’s disease. Amsterdam: Elsevier; 1993. p. 159-63
  8. Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behçet’s Disease. Semin Arthritis Rheum 1998;27:197-217
  9. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338-47
  10. Çirkinoğlu MS, Demir S, Bilginer Y, Özen S. Behçet’s disease in children: single-center experience. Turk Pediatri Ars 2019;54:179- 84
  11. Soylu M, Şekeroglu HT, Erdem E, Demircan N. Behçet’s Disease: The Clinical and Demographic Characteristics of 406 Patients. Turk J Rheumatol 2012;27:115-20
  12. Sachetto Z, Mahayri N, Ferraz RH, Costallat LT, Bertolo MB. Behçet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int 2012;32:2063-7
  13. Zouboulis CC, Vaiopoulos G, Marcomichelakis N, Palimeris G, Markidou I, Thouas B, et al. Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades- Behçet’s disease in Greece. Clin Exp Rheumatol 2003;21(4 Suppl 30):19-26
  14. Bang DS, Oh SH, Lee KH, Lee ES, Lee SN. Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci 2003;18:231-5
  15. Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunasti S, et al. Demographic and clinical properties of juvenile-onset Behçet’s disease: